Recent Quotes (30 days)

You have no recent quotes
chg | %

Sharon Bio-Medicine Ltd.  

(Public, BOM:532908)   Watch this stock  
Find more results for BOM: 532908
-0.34 (-4.83%)
Feb 19 - Close
BOM real-time data - Disclaimer
Currency in INR
Range 6.69 - 7.10
52 week 4.98 - 10.10
Open 7.10
Vol. 37,662.00
Mkt cap 796.87M
P/E     -
Div/yield     -
EPS     -
Shares 118.94M
Beta     -
Inst. own     -

Key stats and ratios

Q1 (Mar '16) 2016
Net profit margin -429.81% -
Operating margin -301.98% -
EBITD margin - -
Return on average assets -74.91% -
Return on average equity - -
CDP Score - -


C-312 BSEL Tech Park,, Sector 30(A),Vashi,
+91-22-67944000 (Phone)
+91-22-67944001 (Fax)

Website links


Sharon Bio-Medicine Limited is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and commercialization of pharmaceutical products. The Company operates in three segments, which include Active Pharma Ingredients (API's), Formulations and Toxicology. The Company offers various Active Pharmaceutical Ingredients, including Ketoconazole, Trimetazidine Di HCI, Glimepiride, Eperisone HCI, Memantine HCI, Telmisartan, Nifedipine, Aripiprazole and Atomoxetine HCI. The Company offers various intermediate products, including Cis Bromo Benzoate, N-Acetyl-4(4-Hydroxy Phenyl) Piperazine, Cis Tosylate and Tri Ethyl Benzyl Ammonium Chloride. The Company also offers various services, including preclinical toxicology on small animals, chemical process development and scale up, formulation development, analytical method development, drug master file (DMF) and dossier preparation, and commercial manufacturing of intermediates, actives and finished dosages.

Officers and directors

Savita Satish Gowda Executive Chairman of the Board, Chief Executive Officer, Managing Director
Deepali Bhatia Compliance Officer, Company Secretary
Lalit Misra Whole-Time Director